药学期刊药品不良反应案例报道的要点探讨  

Discussion on the Key Points of Article Describing Adverse Drug Reaction Case in Pharmaceutical Journal

作　　者：范燕[1] 汤韧[1] 井春梅[1] 李馨龄[1] 

机构地区：[1]国家食品药品监督管理总局药品评价中心,北京100045

出　　处：《中国药物警戒》2017年第2期99-101,共3页Chinese Journal of Pharmacovigilance

摘　　要：目的为药学期刊中药品不良反应(ADR)案例报道类论文的写作、审核、编辑提供参考。方法汇总药学类科技核心期刊相关论文的情况,结合ADR个例报告评价要点,分析案例报道类论文写作、审核、编辑时应注意的要点。结果和结论严重的、新的、罕见的ADR参考价值较高,文章内容应围绕ADR性质的判断和病例关联性分析,展开病例情况描述和文献分析,总结或推测该ADR的发生特点和可能机制,提出临床用药应注意的问题以及预防和处理类似ADR的措施。Objective To provide the reference for writing, auditing and editing of phamaceutical journal articles about , drug reaction （ADR） case reports. Methods By collecting the correlative papers in science and technology core journals of pharmacy category, combining the key points of evaluation of ADR case reports, the key points of writing, auditing and editing of the case report were analyzed. Results ＆ Conclusion The reference value of serious, unlisted and rare ADRs is higher. The contents of article should be around nature judgement of ADR case and causality analysis. Through describing a case and analyzing literature, the articles should summarize or speculate the characteristics and the possible mechanisms, put forward problems that should be paid attention in clinical medication and measures to prevent and deal with similar ADRs.

关 键 词：药品不良反应 案例报道 论文 要点 

分 类 号：R994.11[医药卫生—毒理学]